Intervention Review

Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis

  1. Janet Pope1,*,
  2. D Fenlon2,
  3. A Thompson3,
  4. Beverley Shea4,
  5. Dan Furst5,
  6. George A Wells6,
  7. Alan Silman7

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 27 APR 1998

Assessed as up-to-date: 9 SEP 2007

DOI: 10.1002/14651858.CD000954


How to Cite

Pope J, Fenlon D, Thompson A, Shea B, Furst D, Wells GA, Silman A. Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis. Cochrane Database of Systematic Reviews 1998, Issue 2. Art. No.: CD000954. DOI: 10.1002/14651858.CD000954.

Author Information

  1. 1

    University of Western Ontario, Dept of Medicine and Epidemiology and Biostatistics, London, Ontario, Canada

  2. 2

    London Health Sciences Centre, University of Western Ontario, Department of Surgery, London, Ontario, Canada

  3. 3

    St Joseph's Health Care, Department of Rheumatology, London, Ontario, Canada

  4. 4

    University of Ottawa, Institute of Population Health, Ottawa, Ontario, Canada

  5. 5

    Virginia Mason Research Center, Seattle, WA 98101, USA

  6. 6

    University of Ottawa Heart Institute, Cardiovascular Research Reference Centre, Ottawa, Ontario, Canada

  7. 7

    University of Manchester, ARC Epidemiology Research Unit, Manchester, UK

*Janet Pope, Dept of Medicine and Epidemiology and Biostatistics, University of Western Ontario, St. Joseph's Health Care, 268 Grosvenor St, London, Ontario, N6A 4V2, Canada. Janet.Pope@sjhc.london.on.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 27 APR 1998

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J. F. Hernekamp, H. Klein, K. Schmidt, U. Kneser, T. Kremer, 5-HT2a receptor antagonism reduces burn-induced macromolecular efflux in rats, European Journal of Trauma and Emergency Surgery, 2015,

    CrossRef